FDAnews
www.fdanews.com/articles/197073-quidel-gets-emergency-clearance-for-covid-19-diagnostic
15 minutes

Quidel Gets Emergency Clearance for COVID-19 Diagnostic

May 12, 2020

Quidel has received an Emergency Use Authorization from the FDA for its Sofia 2 rapid antigen COVID-19 diagnostic test.

The assay is designed for use with the company’s Sofia 2 fluorescent immunoassay analyzer for rapidly detecting the coronavirus in nasal or nasopharyngeal samples.

The immunoassay analyzer delivers automated test results in 15 minutes.

View today's stories